# LTC Properties Inc: financial statements, quarterly

LTC · NYSE · CIK 887905 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ltc.md) · [Financials](/companies/ltc/financials.md) · [Filings](/companies/ltc/filings.md) · [Insiders](/companies/ltc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ltc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [49.3](/filings/0001558370-25-001395.md) | [50.2](/filings/0001558370-25-001395.md) | [51.4](/filings/0001558370-25-006304.md) | [50.1](/filings/0001558370-25-010115.md) | [55.8](/filings/0001104659-25-106323.md) | [52.6](/filings/0001558370-25-001395.md) | [49.0](/filings/0001104659-26-056329.md) | [60.2](/filings/0001104659-26-091183.md) | [69.3](/filings/0001104659-25-106323.md) | [84.3 d](/filings/0001104659-26-019178.md) | [95.4](/filings/0001104659-26-056329.md) | [98.9](/filings/0001104659-26-091183.md) |
| Operating income | $m | [22.3](/filings/0001558370-24-013751.md) | [124 d](/filings/0001104659-26-019178.md) | [24.3](/filings/0001558370-25-006304.md) | [19.1](/filings/0001558370-24-010291.md) | [53.3](/filings/0001104659-25-106323.md) | [50.2 d](/filings/0001104659-26-019178.md) | [49.6](/filings/0001104659-26-056329.md) | [48.5](/filings/0001104659-26-091183.md) | [49.8](/filings/0001104659-25-106323.md) | [56.9 d](/filings/0001104659-26-019178.md) | [56.4](/filings/0001104659-26-056329.md) | [54.7](/filings/0001104659-26-091183.md) |
| Interest expense | $m | [12.7](/filings/0001558370-23-016867.md) | [12.4 d](/filings/0001558370-24-001256.md) | [11.0](/filings/0001558370-24-006117.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0 d](/filings/0001558370-23-016867.md) | [0.0 d](/filings/0001104659-26-019178.md) | not reported | not reported | not reported | not reported | not reported | [(0.1)](/filings/0001104659-26-091183.md) | [0.0](/filings/0001104659-25-106323.md) | [0.2 d](/filings/0001104659-26-019178.md) | [0.1](/filings/0001104659-26-056329.md) | [0.2](/filings/0001104659-26-091183.md) |
| Net income | $m | [22.2](/filings/0001558370-24-013751.md) | [28.2 d](/filings/0001104659-26-019178.md) | [24.2](/filings/0001558370-25-006304.md) | [19.4](/filings/0001558370-25-010115.md) | [29.4](/filings/0001104659-25-106323.md) | [18.1 d](/filings/0001104659-26-019178.md) | [20.7](/filings/0001104659-26-056329.md) | [15.1](/filings/0001104659-26-091183.md) | [(20.0)](/filings/0001104659-25-106323.md) | [102 d](/filings/0001104659-26-019178.md) | [23.6](/filings/0001104659-26-056329.md) | [29.6](/filings/0001104659-26-091183.md) |
| Diluted EPS | $ per share | [0.54](/filings/0001558370-25-001395.md) | [0.67](/filings/0001558370-25-001395.md) | [0.56](/filings/0001558370-25-006304.md) | [0.44](/filings/0001558370-25-010115.md) | [0.66](/filings/0001104659-25-106323.md) | [0.39](/filings/0001558370-25-001395.md) | [0.45](/filings/0001104659-26-056329.md) | [0.32](/filings/0001104659-26-091183.md) | [(0.44)](/filings/0001104659-25-106323.md) | not reported | [0.48](/filings/0001104659-26-056329.md) | [0.56](/filings/0001104659-26-091183.md) |
| Basic EPS | $ per share | [0.54](/filings/0001558370-25-001395.md) | [0.67](/filings/0001558370-25-001395.md) | [0.56](/filings/0001558370-25-006304.md) | [0.44](/filings/0001558370-25-010115.md) | [0.66](/filings/0001104659-25-106323.md) | [0.40](/filings/0001558370-25-001395.md) | [0.45](/filings/0001104659-26-056329.md) | [0.33](/filings/0001104659-26-091183.md) | [(0.44)](/filings/0001104659-25-106323.md) | not reported | [0.48](/filings/0001104659-26-056329.md) | [0.57](/filings/0001104659-26-091183.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [11.3](/filings/0001558370-23-016867.md) | [20.3](/filings/0001558370-25-001395.md) | [9.0](/filings/0001558370-24-006117.md) | [6.2](/filings/0001558370-24-010291.md) | [35.0](/filings/0001558370-24-013751.md) | [9.4](/filings/0001104659-26-019178.md) | [23.3](/filings/0001558370-25-006304.md) | [7.6](/filings/0001558370-25-010115.md) | [17.9](/filings/0001104659-25-106323.md) | [14.4](/filings/0001104659-26-091183.md) | [21.7](/filings/0001104659-26-056329.md) | [40.4](/filings/0001104659-26-091183.md) |
| Total assets | $m | [1,868](/filings/0001558370-23-016867.md) | [1,855](/filings/0001558370-25-001395.md) | [1,818](/filings/0001558370-24-006117.md) | [1,891](/filings/0001558370-24-010291.md) | [1,872](/filings/0001558370-24-013751.md) | [1,786](/filings/0001104659-26-019178.md) | [1,776](/filings/0001558370-25-006304.md) | [1,795](/filings/0001558370-25-010115.md) | [2,044](/filings/0001104659-25-106323.md) | [2,062](/filings/0001104659-26-091183.md) | [2,102](/filings/0001104659-26-056329.md) | [2,177](/filings/0001104659-26-091183.md) |
| Total liabilities | $m | [1,007](/filings/0001558370-23-016867.md) | [939](/filings/0001558370-25-001395.md) | [900](/filings/0001558370-24-006117.md) | [908](/filings/0001558370-24-010291.md) | [830](/filings/0001558370-24-013751.md) | [733](/filings/0001104659-26-019178.md) | [726](/filings/0001558370-25-006304.md) | [750](/filings/0001558370-25-010115.md) | [999](/filings/0001104659-25-106323.md) | [900](/filings/0001104659-26-091183.md) | [919](/filings/0001104659-26-056329.md) | [835](/filings/0001104659-26-091183.md) |
| Long-term debt | $m | [956](/filings/0001558370-23-016867.md) | [891](/filings/0001558370-25-001395.md) | [860](/filings/0001558370-24-006117.md) | [861](/filings/0001558370-24-010291.md) | [785](/filings/0001558370-24-013751.md) | [685](/filings/0001104659-26-019178.md) | [682](/filings/0001558370-25-006304.md) | [696](/filings/0001558370-25-010115.md) | [945](/filings/0001104659-25-106323.md) | [842](/filings/0001104659-26-091183.md) | [867](/filings/0001104659-26-056329.md) | [777](/filings/0001104659-26-091183.md) |
| Shareholders' equity | $m | [825](/filings/0001558370-23-016867.md) | [881](/filings/0001558370-25-001395.md) | [886](/filings/0001558370-24-006117.md) | [889](/filings/0001558370-24-010291.md) | [948](/filings/0001558370-24-013751.md) | [961](/filings/0001104659-26-019178.md) | [962](/filings/0001558370-25-006304.md) | [958](/filings/0001558370-25-010115.md) | [958](/filings/0001104659-25-106323.md) | [1,075](/filings/0001104659-26-091183.md) | [1,110](/filings/0001104659-26-056329.md) | [1,269](/filings/0001104659-26-091183.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [32.4 d](/filings/0001558370-24-013751.md) | [25.6 d](/filings/0001104659-26-019178.md) | [21.1](/filings/0001558370-25-006304.md) | [37.0 d](/filings/0001558370-25-010115.md) | [34.0 d](/filings/0001104659-25-106323.md) | [33.9 d](/filings/0001104659-26-019178.md) | [29.6](/filings/0001104659-26-056329.md) | [30.0 d](/filings/0001104659-26-091183.md) | [38.4 d](/filings/0001104659-25-106323.md) | [37.9 d](/filings/0001104659-26-019178.md) | [30.8](/filings/0001104659-26-056329.md) | [34.4 d](/filings/0001104659-26-091183.md) |
| Dividends paid | $m | [23.6 d](/filings/0001558370-24-013751.md) | [24.0 d](/filings/0001104659-26-019178.md) | [24.6](/filings/0001558370-25-006304.md) | [24.8 d](/filings/0001558370-25-010115.md) | [25.3 d](/filings/0001104659-25-106323.md) | [25.8 d](/filings/0001104659-26-019178.md) | [27.3](/filings/0001104659-26-056329.md) | [26.3 d](/filings/0001104659-26-091183.md) | [26.5 d](/filings/0001104659-25-106323.md) | [27.4 d](/filings/0001104659-26-019178.md) | [29.2](/filings/0001104659-26-056329.md) | [29.8 d](/filings/0001104659-26-091183.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [40.6](/filings/0001558370-23-016867.md) | [41.2](/filings/0001558370-24-006117.md) | [41.2](/filings/0001558370-24-010291.md) | [41.2](/filings/0001558370-24-013751.md) | [43.0](/filings/0001558370-25-006304.md) | [43.5](/filings/0001558370-25-010115.md) | [44.4](/filings/0001104659-25-106323.md) | [45.7](/filings/0001104659-26-056329.md) | [46.0](/filings/0001104659-26-091183.md) | [46.1](/filings/0001104659-25-106323.md) | [49.0](/filings/0001104659-26-056329.md) | [52.2](/filings/0001104659-26-091183.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 53,905,563 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0001104659-26-091183.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.